Affective temperaments and psychotropic adherence

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 1142-1147

  Kamei, Kimie ^a   Terao, Takeshi ^a   Katayama, Yosuke ^a   Hoaki, Nobuhiko ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adherence; DAI 10; Temperament; VAS

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DOSE RESPONSE; FEMALE; HUMAN; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SCORING SYSTEM; TEMPERAMENT;

ADHERENCE; DAI-10; TEMPERAMENT; VAS;

ADULT; AFFECT; ANXIETY; FEMALE; HUMANS; IRRITABLE MOOD; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; TEMPERAMENT;

EID: 84888367879     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.05.064     Document Type: Article

References (37)

1. Akiskal, H.S., 1995. Toward a temperament-based approach to depression: implications for neurobiologic research. Advances in Biochemical Psychopharmacology 49, 99-112.
2. Akiskal, H.S., Mallya, G., 1987. Criteria for the "soft"bipolar spectrum: treatment implications. Psychopharmacology Bulletin 23, 68-73.
3. Akiskal, H.S., Pinto, O., 1999. The evolving bipolar spectrum. Prototypes I, II, III and IV. Psychiatric Clinics of North American 22, 517-534.
4. Akiskal, H.S., 2007. The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacology Bulletin 40, 99-115.
5. Ahn, J., McCombs, J.S., Jung, C., Croudace, T.J., McDonnell, D., Ascher-svanum, H., Edgell, E.T., Shi, L., 2008. Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program. Value in Health 11, 48-56.
6. Araki, Y., Terao, T., Hoaki, N., Wang, Y., Goto, S., 2012. Bipolar temperaments and light. Journal of Affective Disorders 136, 740-742.
7. Arnau, M.M., Mondon, S., Santacreu, J.J., 2008. Using the treatment and character inventory (TCI) to predict outcome after inpatient detoxification during 100 days of outpatient treatment. Alcohol and Alcoholism 43, 583-588.
8. Ascher-Svanum, H., Zhu, B., Faries, D., Lacro, J.P., Dolder, C.R., 2006a. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. Journal of Clinical Psychiatry 67, 1114-1123.
9. Ascher-Svanum, H., Faries, D.E., Zhu, B., Ernst, F.R., Swartz, M.S., Swanson, J.W., 2006b. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 67, 453-460.
10. Ascher-Svanum, H., Zhu, B., Faries, D.E., Furiak, N.M., Montgomery, W., 2009. Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia. BMC Research Notes 2, 6.
11. Aukst-Margetid, B., Jakovljevid, M., Ivanec, D., Tosid, G., Margetid, B., 2011. Novelty seeking and medication adherence in patients with schizophrenia. Psychiatry Research 186, 141-143.
12. Baldessarini, R.J., Perry, R., Pike, J., 2008. Factors associated with treatment nonadherence among US bipolar disorder patients. Human Psychopharmacol-ogy: Clinical and Experimental 23, 95-105.
13. Becker, M.A., Young, M.S., Ochshorn, E., Diamond, R.J., 2007. The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia. Administration and Policy in Mental Health and Mental Health Services Research 34, 307-314.
14. Cortet, B., Benichou, O., 2006. Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis? Joint Bone Spine 73, e1-e7.
15. Gianfrancesco, F.D., Rajagopalan, K., Sajatovic, M., Wang, R.H., 2006. Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. Psychiatry Research 144, 177-189.
16. Gilmer, T.P., Dolder, C.R., Lacro, J.P., Folson, D.P., Lindamer, L., Garcia, P., Jeste, D.V., 2004. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161, 692-699.
17. Goto, S., Terao, T., Hoaki, N., Wang, Y., 2011. Cyclothymic and hyperthymic temperaments may predict bipolarity in major depressive disorder: a supportive evidence for bipolar II1/2 and IV. Journal of Affective Disorders 129, 34-38.
18. Hoaki, N., Terao, T., Wang, Y., Goto, S., Tsuchiyama, K., Iwata, N., 2011. Biological aspect of hyperthymic temperament: light, sleep, and serotonin. Psychophar-macology 213, 633-638.
19. Hogan, T.P., Awad, A.G., Eastwood, R., 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 13, 177-183.
20. Kohno, K., Hoaki, N., Inoue, T., Nakai, Y., Toyomaki, A., Araki, Y., Hatano, K., Terao, T., 2012. Latitude effect on bipolar temperaments. Journal of Affective Disorders 142, 53-56.
21. Lindenmayer, J.P., Liu-Seifert, H., Kulkarni, P.M., Kinon, B.J., Stauffer, V., Edwards, S.E., Chen, L., Adams, D.H., Ascher-Svanum, H., Buckley, P.F., Citrome, L., Volavka, J., 2009. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. Journal of Clinical Psychiatry 70, 990-996.
22. Liraud, F., Verdoux, H., 2001. Association between temperamental characteristics and medication adherence in subjects presenting with psychotic or mood disorders. Psychiatry Research 102, 91-95.
23. Martinez-Aran, A., Scott, J., Colom, F., Torrent, C., Tabares-seisdedos, R., Daban, C., Leboyer, M., Henry, C., Goodwin, G.M., Gonzalez-Pinto, A., Cruz, N., Sanchez-Moreno, J., Vieta, E., 2009. Treatment nonadherence and neurocognitive impairment in bipolar disorder. Journal of Clinical Psychiatry 70, 1017-1023.
24. Matsumoto, S., Akiyama, T., Tsuda, H., Miyake, Y., Kawamura, Y., Noda, T., Akiskal, K, K., Akiskal, H, S., 2005. Reliability and validity of TEMPS-A in a Japanese nonclinical population: application to unipolar and bipolar depressives. Journal of Affective Disorders 85, 85-92.
25. Nielsen, R.E., Lindstrom, E., Nielsen, J., Levander, S., 2012. DAI-10 is as good as DAI-30 in schizophrenia. European Neuropsychopharmacology 22, 747-750.
26. Novick, D., Haro, J.M., Suarez, D., Perez, V., Dittmann, R.W., Haddad, P.M., 2010. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research 176, 109-113.
27. Olfson, M., Mechanic, D., Hansell, S., Boyer, C.A., Walkup, J., Weiden, P.J., 2000. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services 51, 216-222.
28. Perkins, D.O., Gu, H., Weiden, P.J., McEvoy, Hamer, R.M., Lieberman, J.A., 2008. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry 69, 106-113.
29. Rittmannsberger, H., Pachinger, T., Keppelmuller, P., Wancata, J., 2004. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatric Services 55, 174-179.
30. Robinson, D.G., Woerner, M.G., Alvir, J.M.J., Bilder, R.M., Hinrichsen, G.A., Lieberman, J.A., 2002. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizozffective disorder. Schizophrenia Research 57, 209-219.
31. Sajatovic, M., Valenstein, M., Blow, F.C., Ganoczy, D., Ignacio, R.V., 2006. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders 8, 232-241.
32. Sajatovic, M., Blow, F.C., Kales, H.C., Valenstein, M., Ganoczy, D., Ignacio, R.V., 2007a. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. International Journal of Geriatric Psychiatry 22, 992-998.
33. Sajatovic, M., Valenstein, M., Blow, F., Ganoczy, D., Ignacio, R., 2007b. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatric Services 58, 855-863.
34. Tsutsumi, T., Terao, T., Hatanaka, K., Goto, S., Hoaki, N., Wang, Y., 2011. Association between affective temperaments and brain-derived neurotrophic factor, glyco-gen synthase kinase 3p and Wnt signaling pathway gene polymorphisms in healthy subjects. Journal of Affective Disorders 131, 353-357.
35. Valenstein, M., Blow, F.C., Copeland, L.A., McCarthy, F., Zeber, J.E., Gillon, L., Bingham, C.R., Stavenger, T., 2004. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophrenia Bulletin 30, 255-264.
36. Wang, Y., Terao, T., Hoaki, N., Goto, S., Tsuchiyama, K., Iwata, N., Yoshimura, R., Nakamura, J., 2011. Type A behavior pattern and hyperthymic temperament: possible association with bipolar IV disorder. Journal of Affective Disorders 133, 22-28.
37. Zeber, J.E., Copeland, L.A., Good, C.B., Fine, M.J., Bauer, M.S., Kilbourne, A.M., 2008. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. Journal of Affective Disorders 107, 53-62.